Freve Jonathan
SEC CIK 1664466 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DMRA | Damora Therapeutics, Inc. | CFO | 12.0K | $31.9K | — | 3 | 2021-08-18 | 2021-12-03 |
Most active insiders at DMRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schambye Hans T. | CEO, Dir | — | $15.0K |
| 2 | Winslow Garrett | GC | — | $12.8K |
| 3 | Firmani Lori | CFO | — | $2,890 |
| 4 | Sattarzadeh Sherwin | COO | — | — |
| 5 | Bruno Julianne | Dir | — | — |
| 6 | Hewes L. Becker | Chief Medical Off | — | — |
| 7 | Fairmount Healthcare Fund II L.P. | 10% | — | — |
| 8 | Jarrett Jennifer | See Remarks, Dir | — | — |
Freve Jonathan made no open-market trades at DMRA in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-06 | 2021-12-03 | DMRA | Damora Therapeutics, Inc. | Freve Jonathan | CFO | P - Purchase | $2.49 | +4,000 | 12.0K | +50% | +$9,960 | |
| 2021-11-09 | 2021-11-08 | DMRA | Damora Therapeutics, Inc. | Freve Jonathan | CFO | P - Purchase | $3.40 | +3,000 | 8,000 | +60% | +$10.2K | |
| 2021-08-19 | 2021-08-18 | DMRA | Damora Therapeutics, Inc. | Freve Jonathan | CFO | P - Purchase | $3.92 | +3,000 | 5,000 | +150% | +$11.8K |
Purchase Sale Sale after option exercise All abbreviations